Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, WOM, DEI

Rosy Debuts New Content Focused on Menopause and Migraine Education

The Women's Health Platform Will Make Evidence-Based Resources More Accessible.

DALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common health concerns for women throughout their lifespans, announces an expanded focus beyond sexual wellness. Through its new sponsorship from Pfizer, one of the world's premier biopharmaceutical companies, Rosy will provide women in the U.S. with free evidence-based resources, rolled out in two phases. The first will focus on menopause and the second on migraine, with the overall goal of empowering women to take their health into their own hands.

We're thrilled to be building out our network and offering free educational resources to women, empowering them to confidently take action regarding important, lifetime health concerns.

Lyndsey Harper MD (Rosy's CEO and Founder) created the first-of-its-kind app to bring women personalized solutions for their health and wellness; the platform supports adult women across their lifecycle, from hormonal health through menopause and beyond. Rosy currently serves women between 17 - 91 years old. When signing up for Rosy, each user takes a comprehensive Wellness Quiz, allowing Rosy to personalize an evidence-based, CBT-informed program with their unique concerns and priorities in mind. Since launching in 2019, Dr. Harper and her team have firmly established Rosy's evidence-based approach ? more than 11% of OB/GYNs nationwide recommend Rosy to their patients. While initially focused on sexual wellness, Rosy has expanded to include a wider range of women's health concerns, including endometriosis, PCOS, and more.

Each year, an estimated 1 million Americans reach menopause, which can coincide with symptoms like vaginal dryness, decreased sensation and libido, pelvic floor issues, and urinary problems. Historically, these issues have gone ignored and unaddressed, with 73% of women not receiving treatment. Through the first phase of the sponsorship from Pfizer, Rosy will create a series of modules to increase awareness surrounding menopause-related topics; these include symptoms, diagnosis, lifestyle change to support symptom relief, and potential treatment options. By equipping patients with knowledge and resources specific to menopause and their unique health concerns and goals, the aim is to empower them to make informed decisions and enhance their overall wellbeing.

During phase two, focus will shift towards patient awareness modules tailored to the unique needs of women suffering from migraine, including diagnosis, symptoms, and treatment options. Migraine is the leading cause of disability worldwide among young adult women, with reproductive hormones often playing a role in their frequency. While migraine symptoms are extremely common, with 1 in 5 women suffering from them worldwide, many people go undiagnosed and untreated for a variety of reasons. Rosy aims to better inform women about migraine symptoms so that they seek out a medical professional and discuss solutions that improve their quality of life.

"We're thrilled to be building out our network and offering free educational resources to women, empowering them to confidently take action regarding important, lifetime health concerns. Our larger goal is not just to inform women, but also provide them with personalized recommendations for evidence-based interventions to support them on their journey to optimal health. With continued scale, our educational modules have the ability to change not only the health of individuals, but the health of larger populations as well." said Lyndsey Harper, MD, Founder and CEO of Rosy.

Physicians, providers, and hospital systems interested in recommending Rosy to their female patients are welcome to email [email protected]. For media inquiries, please contact [email protected].

About Rosy:

Rosy is a first-of-its-kind platform that offers personalized and holistic solutions for women's wellness. Originally focused on sexual health, the app has expanded into other underserved aspects of women's health, including endometriosis, fibroids, menopause, migraines, and more. Offerings include customized Wellness Plans, individual and group intimacy coaching, audio and written erotica, educational videos, supportive online community, and much more. Rosy is the first physician-founded platform supporting women throughout their lifetime.

In 2022, Rosy won the UCSF Digital Health Rising Star Award in the Consumer Wellness Category, as well as the Webby Award for Best Visual Design - Aesthetic in the Apps and Software Category and in 2023, Lyndsey Harper, MD and Rosy were awarded the Women's Health Innovation Summit (WHIS) Judge's Choice Award.

Website: https://meetrosy.com/

Instagram: @meet_rosy

Linkedin: https://www.linkedin.com/company/meet_rosy/

The Rosy App: https://meetrosy.app.link/h1yxnl3eknb

Media Contact

Rachel Van Dolsen, Band of Insiders, 1 9142604636, [email protected], https://www.rachelvandolsen.com/


These press releases may also interest you

at 19:40
{DATELINECITY_DATE_GLOBENEWSWIRE_BUG}}Halo Dental Technologies, the developer behind the much-anticipated Halo Digital Mirror, is bringing the innovation to Journées Dentaires Internationales du Québec (JDIQ), a flagship event organized annually by...

at 19:00
Questor Technology Inc. ("Questor" or the "Company") announces the departure of Vice President Operations and Customer Experience, Ryan Pilsner, effective today. On behalf of the employees and Board of Directors, the Company thanks Ryan for his...

at 18:20
Flotek Industries, Inc. ("Flotek" or the "Company") today announced that David Nierenberg is stepping down from his position as a member of the Company's Board of Directors.  ...

at 17:45
WD & Associates ("WD"), a division of Patriot Growth Insurance Services, LLC ("Patriot Growth"), is providing individuals with notice of an incident that may impact the privacy of certain information. The confidentiality, privacy, and security of...

at 17:35
WM Technology, Inc. ("WM Technology" or the "Company") , a leading technology and software infrastructure provider to the cannabis industry, today announced its financial results for the first quarter ended March 31, 2024 and the full year ending...

at 17:30
Genifi inc. ("genifi" or the "Company") today announced that it held its annual and special meeting of shareholders earlier today and that shareholders approved the election of all director nominees, the re-approval of MNP LLP as auditor of the...

News published on and distributed by: